Agenda
Jump To:
Session 1: Pricing & Reimbursement
Session 2: Targeted Therapies & Companion Diagnostics
Session 3: Manage & Engage your stakeholders
Jump To:
Session 1: Pricing & Reimbursement
Session 2: Targeted Therapies & Companion Diagnostics
Session 3: Manage & Engage your stakeholders
| Time | Topic |
|---|---|
| 07:30 - 08:25 | Coffee and Registration |
| 08:25 - 08:30 | Opening address |
| 08:30 - 09:00 | Chairman Address & Presentation - Chuck Stevens, Vice President, Parexel |
| Session 1: Pricing & Reimbursement | |
| 09:00 - 09:35 |
A brave new world: The trends, challenges and strategies for effectively commercializing novel oncology products
With: Chris Boerner, Vice President of Marketing, Seattle Genetics
|
| 09:35 - 10:10 |
From evidence-based to value-based medicines: What does this mean for your development strategy?
With: Darshan Wariabharaj, Director, Drug Regulatory Affairs, Novartis Oncology
|
| 10:10 - 10:45 |
From evidence-based to value-based medicines: What does this mean for your commercialization strategy?
With: Quanwu Zhang, Global Evidence & Value Development, Sanofi R & D
|
| 10:45 - 11:15 | Networking coffee break |
| 11:15 - 11:50 |
Evolution of Medicare and its Impact on Oncology Product Coverage and Reimbursement
With: Debbie Warner, Vice President Oncology Market Access, Kantar Health
|
| 11:50 - 12:25 |
A Health Plan PBM perspective on managing specialty care: Learn how your therapy will be viewed covered and reimbursed
With: Raechele McMahan, Head, Clinical Strategy & Development, Aetna Pharmacy
|
| 12:25 - 13:25 | Lunch |
| 13:25 - 14:00 |
The importance of patient reported outcomes for your market access strategy
With: Nathan White, Executive Director, Access & Reimbursement, InVentiv Health Steven Bloom, Vice President, ZioPharm
|
| 14:00 - 14:35 |
Panel: How Payers are working with Oncology pathways: Learn how to align your reimbursement strategy
With: Michael Sherman, CMO, Harvard Pilgrim Dr Beckie Fenrick, Senior Director, BlueCross BlueShield's Raechele McMahan, Head, Clinical Strategy & Development,, Aetna Pharmacy
|
| 14:35 - 15:10 | Networking coffee break |
| 15:10 - 15:45 |
The Patient's Voice in Market Access
With: Tim Turnham, Executive Director, Melanoma Research Foundation
|
| Session 2: Targeted Therapies & Companion Diagnostics | |
| 15:45 - 16:20 |
Panel: Deduce the new role of companion diagnostic tests in getting access for your targeted therapy
With: Marc Watrous, Vice President Payer Account Management, Genentech Dana Evans, Medical Director, Genentech Raechele McMahan, Head, Clinical Strategy & Development, Aetna Pharmacy
|
| 16:20 - 16:55 |
Ensuring effective market access for the diagnostic associated your targeted therapy
With: Charles Mathews, Vice President, Boston Healthcare
|
| 16:55 - 17:30 |
Super Panel discussion: Build your commercial structure for targeted therapies to gain market access
Led by Michael Sherman, CMO, Harvard Pilgrim With... Aetna, Sanofi Oncology, BlueCross BlueShield's, Bayer and Novartis
|
| 17:30 | Networking Drinks Reception in Exhibition Area |
| Time | Topic |
|---|---|
| 08:20 - 08:50 | Coffee and Registration |
| 08:50 - 09:00 | Chairman's opening - Nathan White, Executive Director, Access & Reimbursement, InVentiv Health |
| 09:00 - 09:45 |
Diagnostic: Pricing Strategy Manage diagnostic approval processes
With: Laura Housman, Executive Director, Market Access and Pricing, Novartis Molecular Diagnostics William Pignato, Global Head, Regulatory Affairs, Novartis Molecular Diagnostics
|
| 09:45 - 10:20 |
Case Study: How to assess threat from mature products and generics when launching a new therapy
With: Suraj Moorthy, Director of Strategy & Portfolio Management, Sanofi Oncology
|
| 10:20 - 10:55 |
Health Plans and Oncologists: The Bumpy Road to Patient Access
With: Dawn Holcombe, President DGH Consulting Dawn Holcombe, President DGH Consulting
|
| 10:55 - 11:35 | Networking coffee break |
| 11:35 - 12:10 |
Targeted therapies: Ensure Access for Selected populations
With: Jason Carlin, Deputy Director Marketing Science, Bayer Healthcare Andrea Adams, Associate Director Customer Analytics, Bristol-Myers Squibb
|
| 12:10 - 12:45 |
Pre and post launch strategy: understand how to maximise product uptake:
With: Dr Andree Bates, President, Eularis
|
| 12:45 - 13:45 | Lunch |
| Session 3: Manage & Engage your stakeholders | |
| 13:45 - 14:20 |
Panel: Create value-winning strategies by effective patient group engagement throughout the value chain of R&D, marketing, and market access:
Led by: Siobhan Cavanaugh, Principal, Siobhan Cavanaugh Consulting Eric Stanek,VP Research, Medco Research Institute Tim Turnham, Executive Director, Melanoma Research Foundation Durhane Wong-Reiger, Chair, International Alliance of Patient Organizations
|
| 14:20 - 14:55 |
Understand the benefits of working with a new stakeholder: Specialty Pharmacy
With: Rebecca Shanahan, Board Member, Oncology Plus Josh Rademacher, Vice President, Oncology Plus
|
| 14:55 - 15:40 |
Panel: The new Oncology Influencers: Why the Data Race, Partnerships, and transparency are Critical to Your Access Strategy
With: Darin T. Rubin, M.P.H, M.B.A., Pulse of the Patient Anthony Davino, Vice President Manufacturer Relations, Armada Healthcare Ed Rodgers, Executive Directors, Via Oncology John Yetter, Director, Oncology Payer Marketing, Bristol-Myers Squibb Mark Neville, Vice President, Sales & Marketing, Diplomat Specialty Pharmacy Stuart Genschaw, Executive Director, Cancer & Hematology Centers of Western Michigan
|
| 15:40 - 15:50 | Chairman - Closing remarks - Nathan White, Executive Director, Access & Reimbursement, InVentiv Health |
| 15:50 | End of Conference! |